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ABSTRACT OF THE DISSERTATION
A NEUROIMAGING WEB INTERFACE FOR DATA ACQUISITION,
PROCESSING AND VISUALIZATION OF MULTIMODAL BRAIN IMAGES
by
Gabriel Lizarraga
Florida International University, 2018
Miami, Florida
Professor Malek Adjouadi, Major Professor
Structural and functional brain images are generated as essential modalities for
medical experts to learn about the different functions of the brain. These images are
typically visually inspected by experts. Many software packages are available to
process medical images, but they are complex and difficult to use. The software
packages are also hardware intensive. As a consequence, this dissertation proposes a
novel Neuroimaging Web Services Interface (NWSI) as a series of processing
pipelines for a common platform to store, process, visualize and share data.
The NWSI system is made up of password-protected interconnected servers
accessible through a web interface. The web-interface driving the NWSI is based on
Drupal, a popular open source content management system. Drupal provides a userbased platform, in which the core code for the security and design tools are updated
and patched frequently. New features can be added via modules, while maintaining
the core software secure and intact. The webserver architecture allows for the
visualization of results and the downloading of tabulated data. Several forms are
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available to capture clinical data. The processing pipeline starts with a FreeSurfer
(FS) reconstruction of T1-weighted MRI images. Subsequently, PET, DTI, and
fMRI images can be uploaded.
The Webserver captures uploaded images

and performs essential

functionalities, while processing occurs in supporting servers. The computational
platform is responsive and scalable. The current pipeline for PET processing
calculates all regional Standardized Uptake Value ratios (SUVRs). The FS and
SUVR calculations have been validated using Alzheimer's Disease Neuroimaging
Initiative (ADNI) results posted at Laboratory of Neuro Imaging (LONI). The NWSI
system provides access to a calibration process through the centiloid scale,
consolidating Florbetapir and Florbetaben tracers in amyloid PET images. The
interface also offers onsite access to machine learning algorithms, and introduces
new heat maps that augment expert visual rating of PET images. NWSI has been
piloted using data and expertise from Mount Sinai Medical Center, the 1Florida
Alzheimer’s Disease Research Center (ADRC), Baptist Health South Florida,
Nicklaus Children's Hospital, and the University of Miami. All results were obtained
using our processing servers in order to maintain data validity, consistency, and
minimal processing bias.
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1.
1.1

Introduction

Neuroimaging Web Services Interface and Research Significance

This dissertation introduces a new web interface and a set of computational and machine
learning algorithms to store and process neuroimaging data. Non-invasive brain imaging
modalities contribute considerably to the understanding of brain structure and
functionality [1]. MRI (Magnetic Resonance Imaging), Positron Emission Tomography
(PET), Diffusion Tensor Imaging (DTI), and Functional Magnetic Resonance Imaging
(fMRI) scans, among others, allow clinicians and experts to advance their research and
take informed decisions on the diagnosis and the planning of clinical and therapeutic
interventions that could follow. The images obtained by these scans must first be preprocessed in order to convert them into numeric values that can be objectively assessed
and analyzed. Hospitals and other research institutions can then capture, store, and view
brain scans on their own picture archiving and communication system (PACS); but
performing additional processing is often computationally taxing, requiring specialized
software, hardware infrastructure, and image processing expertise that our Neuroimaging
Web Services Interface (NWSI) is designed to offer.
In addition to the need of individual investigators to test and validate results, there is a
larger neuroscience community in hospitals, clinics and medical institutes that can benefit
from this integrated processing platform. Data mining and data sharing present many
challenges and opportunities to visualize and assess brain activity maps that can be
viewed as a form of “neural choreography” [2]. Data sharing, which remains limited due
to the different institutional and privacy constraints, should be encouraged within the
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scientific community to increase the value of research. The Governing Council of the
Organization for Human Brain Mapping (OHBM), the primary international organization
dedicated to neuroimaging research, highlighted in 2001 certain challenges in the field of
databases in neuroimaging, most of which we still face, such as (a) management of the
volume and the variety of forms in which the data is presented, (b) methods for the
processing of brain images, (c) accessibility of data, and (d) the lack of access to
neuroimaging results to investigators [3, 4].
The proposed Neuroimaging Web Services Interface (NWSI) serves as an automated,
responsive and scalable neuroimaging database solution. This new design serves also as a
cyber physical system in that it offers users access to neuroimaging algorithms through
the internet and provides the needed computational resources with all the required
processing, storage capabilities, security and operational maintenance. It is comprised of
a Web-Interface, and a set of replica Linux servers that perform specific tasks. Interacting
with the system requires minimal computing knowledge, equivalent to what is expected
from social media or similar type web interface [5].
NWSI is equipped with various useful tools, such as Brain Extraction Tool (BET), brain
image registration, and image format conversion. The current implementation includes:
(1) automatic quantification of volumes from anatomical MRIs, (2) 18F-Florbetapir and
18F-Florbetaben for Alzheimer’s disease (AD), (3) FDG PET analysis for Epilepsy, and
(4) DTI image processing for both AD and epilepsy. All the data results are collected in
files and into a MySQL database, and can be exported into tabulated files and image files.
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The accumulated data can be used in future pipelines as input to multimodal and
longitudinal studies.
NWSI utilizes an embedded modified version of the Papaya viewer (a JavaScript medical
research image viewer), developed by University of Texas Health Science Center. The
viewer allows interactive display of cerebral regions, diffusion images, and PET data. All
images are co-registered to the anatomical MRI as part of the pipeline; they can be
displayed on the same viewer in stacked layers. Moreover, results have been validated by
comparison to existing processed data, such as from the ADNI database, which provides
an excellent source of raw and post-processed data for validating the various functions of
NWSI.
NWSI has created options to display the PETs in grayscale or spectrum color schemes. It
also provides a white and gray matter contour that clearly separates the gray matter from
the white matter. This contour provides a more accurate way to rate the PETs as
explained on chapter 4.
Neuroimaging Web Services Interface (NWSI) provides an interface to process medical
images of the brain. It applies the same processing pipelines to all images of the same
modality and provides the capability of performing concurrent quality control via the
interface by multiple experts. The full output of FreeSurfer, including images, is provided
as a download. NWSI also provides access to intermediate steps. For example, while
calculating the SUVR values the regional averages are calculated before they are
normalized by a region of reference. This intermediate output is also provided to the user.
The transparency and options given by NWSI is not matched, to the best of our
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knowledge, by any existing system. NWSI provides a system of alerts and messages that
notify the user when their asynchronous processing has been completed. A help system
for general usage is also provided. These complement the design of the forms that are
built embedded with explanations and help on how to use NWSI. The NWSI Forum
provides a space for other researchers to connect and share knowledge.
NWSI results were validated by comparing its output with data obtained from ADNI and
the Centiloid Project: Global Alzheimer’s Association Interactive Network (GAAIN).
Both validations indicated that the difference in the data processed by NWSI and the data
from GAAIN or ADNI is not statistically significant. NWSI is being actively used by
researchers from multiple universities and hospitals in the US. NWSI provides the SUVR
values in the centiloid scale, which allows the merging of results from different tracers
(Florbetapir and Florbetaben) for PET imaging.
Image restoration is also an important issue with neuroimaging. The images are obtained
from machines that create a representation of the inside of the human body. Removing
noise and other artifacts is an important pre-processing step. We propose a new method
to remove shading, caused by an aliasing artifact. The method corrects the images and
allows the processing steps to extract accurate parameters, such as the intracranial
volume (ICV) for estimating head size.
The SVM classification interface in NWSI provides the user with a simple but powerful
way to conduct a variety of classification experiments on the data. Many options are
selectable by the user:

SMV kernel,

data normalization

methods,

use of

neurophysiological data, among others. The interface provides user-friendly interaction,
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where the user does not have to be familiar with the supporting algorithms. Our Web
Platform is designed for easy access to medical doctors and clinicians, who are interested
in brain research, but do not necessarily, have a computer science background.
Given that the causes of AD are unknown, and a cure is not yet available, early detection
is essential. When patients are cautioned that they have a possibility to develop AD, they
can prepare better for the future and plan for treatment and plan early therapeutic/curative
interventions. One way of detecting the possibility of AD development is to compare the
patient to a population of AD, MCI, and cognitively normal (CN) individuals.
Classifications algorithms, such as SVM (Support Vector machine) are suitable for such a
task. Once the SVM is trained with existing data, a new data point can be placed in the
context of existing subjects, and a classification into one of the prodromal stages of AD
can be obtained.
1.2

General Statement of the Research Area

This research seeks to provide a methodology for medical image processing through
algorithms that provide results validated to current standards. The intent is to implement a
web-based interface that allows 24-hour access to neuroimaging data. Users of the
interface will be able to share their datasets, promoting collaboration among researchers.
1.3

Research Purpose

The research aims to create a web-based multimodal neuroimaging platform. The data
processed on the interface is curated and ready for discovery. NWSI provides a bridge
between the image, as obtained from the scanner, and the numeric values that can be used
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in classification algorithms and statistical analysis software. This is a fundamental step in
the discovery process, providing researchers with results that are validated and can be
trusted. NWSI creates standardized databases and allows the merging of data from
different sources eliminating some of the biases that plague processing in the medical
imaging realm.
1.4

Significance of the Research

Medical image processing is a field that emerged as computer hardware and software
evolved. By doing a multimodal analysis of medical images researchers can learn about
conditions of the brain in its normal and diseased states. NWSI addresses key issues of
image registration, image processing, segmentation, image restoration, and data fusion
(such as for Florbetapir and Florbetaben in PET and Centiloid scaling) and ensures
correctness of the implemented algorithms through quality control and validation
processes. NWSI also proposes a method to improve PET scans binary reading by using
white matter contours. There is no other system, to our knowledge, capable of taking
uploaded medical images and processing them into tabulated data that also provides easy
sharing of information. The image restoration method proposed corrects the images and
allows for accurate processing and parameter extraction.
1.5

Structure of the Research

In Chapter two, relevant research endeavors related to the research work of this
dissertation are described. Chapter 3 introduces the design and architecture of the
NeuroImaging Web Services Interface (NWSI). A detailed description of the system is
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provided, including: (1) the hardware architecture, (2) design aspects of the interface, (3)
and a cost analysis. The data from our research collaborators, including the technical
details regarding its acquisition, and the number of subject for each type of scan is also
provided. This Chapter also describes the design of the SMV classification form.
Chapter 4 is dedicated to research issues involving image processing, and the software
pipelines embedded in the NWSI; these are addressed in Sections 4.1 through 4.7.
Sections 4.8 and 4.9 discuss the advantages of automatic normalization of PET scans and
the importance of white matter contour overlays in binary ratings. Section 4.10 describes
a general method to create heat maps of grain regions. Chapter 4.11 describes and
algorithm for medical image restoration. Section 4.12 describes a classification algorithm
implemented on the web-interface Results are then presented, including many of the
experiments that researchers can conduct with the interface. In Chapter 5 results derived
from the system are presented, and several parts of the systems are validated by
processing external data and comparing the results.
Finally, Chapter 6 concludes with a retrospective of this work together with the key
findings of this research. It also outlines all the essential improvements that were made
possible for the effective use of the interface and suggests future developments that could
augment the proposed web interface.
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2.

2.1

Related Work and Retrospective on Neuroimaging in AD

Existing Neuroimaging Databases

Among the most established and widely recognized efforts to create shared neuroimaging
databases is the Alzheimer's Disease Neuroimaging Initiative (ADNI) database [6], which
currently contains data (some of which are longitudinal) from over 1900 subjects,
encompassing over 4000 MRI and PET scans, as well as clinical, cerebrospinal fluid
(CSF), genetic and biochemical biomarkers, which have been made available to
researchers worldwide, who have made over 14 million downloads. Many other
databases with more specialized audiences exist and have been cataloged in Neuroscience
Information Framework [7]. These include: the Minimal Interval Resonance Imaging in
Alzheimer's Disease database (MIRIAD) [8], the OpenfMRI database [9], NeuroVault
[10], the Virtual Brain (TVB) [11], Neuroimaging Data Model (NI-MD) [12], and the
Vanderbilt University Institute for Imaging Science Center for Computational Imaging
(VUIIS-CCI), XNAT (Extensible Neuroimaging Archive Toolkit)-based repository [13].
The Open Access Series of Imaging Studies (OASIS), made available by the made
available by the Washington University Alzheimer’s Disease Research Center, Harvard
University, the Neuroinformatics Research Group (NRG) at Washington University
School of Medicine, and the Biomedical Informatics Research Network (BIRN), stores
brain MRI data. OASIS currently contains 1098 subjects, 2118 MRI and 1500 PET
images. The dataset is a retrospective compilation of collected from several ongoing
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projects through the ADRC over the course of 30 years. OASIS does not allow users to
upload their own images for processing.
The Collaborative Informatics and Neuroimaging Suite (COINS) [14], is a suite
developed to allow data storage and sharing. The interface allows uploading the
neuroimaging data, but does not provide visualization or data processing capabilities.
2.2

Retrospective on Multimodal Imaging for AD Classification and Prediction

and Measures of Caution to be Considered
According to the Alzheimer Association (www.alz.org): Alzheimer’s disease is the sixthleading cause of death in the United States, and the only cause of death in the top 10 in
the United States that cannot be prevented, cured, or slowed down, killing more than
breast and prostate cancer combined. While death from other diseases has decreased
significantly, from 2000 to 2013, death from Alzheimer’s disease has increased by 71%.
In 2015 alone, the United States will spend 226 Billion dollars to care for people with
Alzheimer’s. It is estimated that by 2050 the national cost could reach a trillion dollars,
unless something is done to improve early diagnosis of the disease and propose new
therapeutic interventions that could slow down the progression of AD. Today 5.3 million
Americans live with Alzheimer’s disease. Someone in the United States will develop the
disease within the next 33 seconds. It is one of the factors contributing to bankrupt
Medicare. AD is not simply memory loss, AD kills. In 2013, 84,000 Americans died of
AD. In 2014, 15.7 million family and friends provided 17.9 billion hours of unpaid care
to AD patients, valued at $218 billion. Nearly half the population over 85 years old will
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have developed AD [15]. While a cure for Alzheimer’s disease will be an ideal solution,
early diagnosis remains a primary requirement in prospective treatment.
Mild Cognitive Impairment (MCI) is a condition which affects the individual’s abilities
to perform certain thinking tasks, while the individual is still able to perform everyday
activities. There are two subtypes of MCI: amnestic MCI (aMCI) and non-amnestic MCI
(na-MCI). It is believed that a-MCI is actually an early stage of AD; memory loss related
to the MCI subgroup, are likely to progress into AD. No single test exists to diagnose
MCI in the most effective way.
Originally, AD was diagnosed without utilizing imaging or biomarkers. In 2007 the
International Working Group (IWG) for New Research Criteria for the Diagnosis of
Alzheimer’s disease changed the basis for diagnosing AD. The new criteria also allowed
diagnosing earlier stages of AD [16]. Brain Medical Imaging is a group of techniques to
create visual representation of the interior of the living brain. These techniques are
minimally invasive or non-invasive and allow researchers to observe the state and
evolution of a diseased or healthy brain.
Brain medical images from multiple modalities as described below are obtained daily in
hospitals around the world. However, not all images collected are suitable for processing.
Historically doctors have looked at these images and derived visual knowledge from
them, such as rating PET images by doing a binary reading. To save scanning time, some
of the images are taken at low resolution (for T1 MRI images, this typically means that
there are less than 64 slides per scan). The resolution of these images is so poor that they
do not reveal any pertinent information when processed in a computer. Other images only
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show parts of the brain and cannot be fed to the algorithms that expect a full brain in
order to estimate volumes and surface areas. Amyloid PET scans are rated based on the
spreading of the tracer to the cortical regions. This will show in the images as a
brightening of the voxels in those areas. The gold standard is to look at these images in
grayscale.
Magnetic Resonance Imaging (MRI) uses a large magnet to polarize the nuclei of
hydrogen in water molecules inside the body and creates images that are representative of
the anatomical features inside the brain, such as volumes and surface areas. MRI was
invented in the 1970s and has proven to be very reliable in showing the anatomy of the
brain. MRI allows the creation of many sequences, including but not limited to T1 and T2
weighted images (obtained by changing the relaxation time after the magnetic
polarization), Fluid Attenuated Inversion Recovery (FLAIR) images (used in analyzing
lesions in white matter, similar to T2 images but with much longer relaxation times),
Diffusion weighted images (DWI) (used in analyzing the diffusion of water molecules in
the brain, and the tracks of the neurons), and Functional MRI (fMRI), which measures
brain functional activity based on the blood-oxygen-level dependent (BOLD) effect. MRI
has improved since its invention, coming from 0.5 Tesla to the current 3 Tesla standard.
Newer 7 Tesla scanners, with their larger signal to noise and contrast to noise ratios,
create higher resolution images of the brain and will potentially allow to capture more
detailed images, and introduce newer processing techniques. A special kind of DWI is the
Diffusion Tensor Imaging (DTI), which maps the white matter tracks and connectivity of
the brain.
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Computed Tomography Scan (CT) combines X-ray measurements from different angles
producing cross-sectional images of the brain. CT is typically used to detect infarcts,
tumors, and calcifications, but provides less anatomical information than the MRI
disciplines. Besides the X-ray based CT, other forms of CT exist, such the Positron
Emission Tomography (PET), and Single-Photon Emission Computed Tomography
(SPECT). PETs are of particular interest in AD research because of their capacity to
measure metabolic processes. When creating a PET image, the subject is injected with a
tracer that emits pairs of gamma rays indirectly emitted by the tracer. PET images are
obtained with the aid of a previously obtained CT image. PETs measure blood flow in
areas of high metabolic activity, capturing brighter pixels where there is more activity.
They are useful in differentiating AD from other types of dementias, and localizing the
focus of epilepsy seizures, among other applications in oncology and other medical
disciplines.
Typical image processing pipelines involve initially processing a T1 MRI image, to
obtain the anatomical data. This anatomical data contains the measurements extracted
from brain structures, such as volumes of cortical and subcortical regions, surface areas
of brain regions, and white matter regions. MRIs are segmented into groups of connected
voxels, each representing a region. The output of processing a T1 MRI includes text files,
containing the numeric measurements, and images that are registered to the T1 and
represent a mapping of the brain, or specific regions of interest (ROIs). For example, in
FreeSurfer the aparc+aseg.mgz file substitutes the intensity for each voxel by a number
that represents the region a given pixel belongs to. This way, it is possible to use it as a
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map of the segmented brain regions. Counting the pixels and multiplying for the voxel
size provides an approximate of the region’s volume. FreeSurfer defines the term
“segmentation” to the partition of the subcortical cerebral regions, while calling
“parcellation” to the cortical regions partition.
Given an MRI segmentation and parcellation, it is possible to register to it an image
created in a different modality. PET and DTI images are diffuse and of lower resolution
than MRI, they don’t have enough information to be segmented by anatomical regions,
but with the help of the MRI analysis it becomes possible to map a voxel from a PET
image to a voxel in an anatomical region. This process also allows registering dissimilar
modalities by bringing them all into the space of the T1 MRI, thus been able to display
the PET and the DTI as a single registered image, allowing for the integrated analysis of
assorted modalities.
Image registration, or co-registration, describes the process of aligning in space two sets
of images from a same imaging modality or a set of images form two different imaging
modalities. Accurate and correct image registration is essential in brain medical image
analysis. Cortical brain regions make up the cerebral cortex, made entirely of gray matter;
gray matter is made up of neuronal bodies. These regions form a ribbon enveloping the
white matter (which contains mainly axons and extra cellular space). This ribbon is very
thin, and any deviation while registering the image will produce incorrect results.
There are many software packages available with options for image registration and MRI
segmentation. Among them: FreeSurfer, FSL, Mango, BrainSuite, Statistical Parametric
Mapping (SPM), and 3D Slicer. The quality of the output depends largely on the quality

13

of the input image (including resolution, noise present in the image, contrast, and
artifacts). These software packages use a combination of knowledge about the structure
of the brain, combined with some sort of optimization algorithm. After the analysis is
complete, a visual inspection and quality control process must ensure that the software
did not make a mistake. A common error with FreeSurfer is to assume a missing region
as atrophied. This causes to map regions that are not really there to white matter or other
parts of the brain, producing volumetric values for areas which should have a zerovolume value.
When PETs are registered to MRI it is necessary to make sure that anatomical features
visible on the PET mapped correctly to their MRI counterparts. Unfortunately, many of
these software packages are based on the Linux operating system and do not provide an
easy way to visualize the output. FreeSurfer provides a viewer, but in order to open it the
user must use the UNIX (a family of operating systems) command line interface to load
the images. This is cumbersome for many researchers and medical personnel, who have
the imaging knowhow but lack the computer skills. Besides the complexity inherent to
the usage of the software, these software packages require extensive computing power.
FreeSurfer takes many hours to finish processing a T1 MRI on a typical server cloud
environment, taking much longer in a personal computer.
Current literature also describes the difficulties of mixing imaging data from
heterogonous sources. There are obvious limitations in mixing data obtained from a 1.5
Tesla scan with a 3 Tesla scan. The 3 Tesla coils produce higher quality images. A more
detailed image will allow the software to better detect the edges of the regions and hence
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producing more accurate structural values. But even if the intracranial volume (ICV) does
not change from the 1 Tesla scan to the 3 Tesla scan, the size of regions can vary, which
could misleadingly indicate a reduction or increase in size of certain regions.
Systematic artifacts and motion artifacts can bias a dataset. Younger participants in a
study might have a tendency to move more than older participant, introducing artifacts
that can be interpreted by the software as region size variations. Even the operator of the
MRI or the scanning environment can introduce biases to the scan acquisition. Another
bias may come from the processing software itself. FreeSurfer has many built-in libraries,
and code created specifically by the FreeSurfer developers, but it also depends on
libraries located on the host computer. That means that if there is a difference in these
libraries it will be reflected on the volumetric values reported by FreeSurfer. This is
known by the FreeSurfer developers, and they warn their users to not use FreeSurferderived data obtained from different software processing platforms in the same study.
Biases sometimes will not affect the results. AD researchers look for variations in
specific brain regions, such as the hippocampus, and don’t look at all at other regions.
But if processing bias affects one of the brain regions under scrutiny, erroneous
conclusions can be drawn. Some biases may affect entire datasets.
When researchers or doctors need their images processed, they typically don’t do it
themselves. The images are sent to private companies or research centers. The processing
facility returns the output as tabulated data rarely disclosing the processing method or
providing the processed images. The researchers and doctors cannot corroborate the
correctness of the output, as quality control is performed by looking at the output images,
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to make sure that the algorithms performed correctly. Two sets of images might also be
processed differently, introducing biases into the dataset.
When looking at the advancement of a disease and the atrophy it produces on brain
regions, the changes are sometimes imperceptible. Cerebral atrophy can be severe in AD
patients, but patients with subtle changes such as in MCI are more difficult to
differentiate from controls. Data biased by processing can introduce changes that might
be interpreted as signs of degeneration (or even regeneration) but are in reality due to the
selected processing pipeline. Having a system that applies the same algorithm to all the
data is key to uniformity and in solving these sorts of problems, which the NWSI is set
out to achieve.
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3.

3.1

Architecture of the Neuro-Imaging Web Services Interface (NWSI)

NWSI Interface

The web-interface driving NWSI is based on Drupal, a popular open source content
management system (CMS), which is the platform for BBC, University of Oxford, the
U.S. Department of Energy, and other well-established organizations. Drupal provides a
user-based platform, in which the core code for the security and design tools are updated
and patched frequently to address vulnerabilities, as well as to add new functionalities.
New features can also be added to Drupal via modules which can be integrated with
Drupal core code, allowing new code to run on Drupal, while maintaining the core
software secure and intact.
The web-interface of NWSI has a simplified design, utilizing forms and uploaded files
for most of the data input. Users of the interface who are not familiar with Linux or its
command line arguments will be able to upload, view, or delete existing data. Figure 1
shows the MRI upload form. All data is de-identified prior to being uploaded to the
server and the user determines whether or not the data on NWSI will be shared with other
users. Access to the site is provided by password protected accounts. Each account
represents a study, and data uploaded under that account can only be viewed by the
owner of such accounts, which can be shared among members of the study.
While the user interaction occurs through the web-interface, a set of replica servers (RSs),
which run on Linux, perform a variety of asynchronous tasks, such as running FreeSurfer
[17] on anatomical MRIs, or registering structural MRI to PET or DTI images. To keep
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the interface responsive, new tasks are sent to a work-loader on the web interface, which
is based on current workload of each RS, sends tasks to one or more available RS(s).
Once the data is copied back to the Web-Server, the Post-Processing Core incorporates it
into the system’s Database and File System. The architecture is scalable, such that new
RSs, which are easy to maintain clones with identical software and capable of performing
all available tasks, can be added on demand to the system.
The asynchronous communication between the web-interface and the RSs is achieved by
securely copying files. Some of these files are data to be processed, while others are
status reports and workload balance data. MRI, PET, DTI, and fMRI images are
processed on the replica servers; but smaller tasks, such as Brain Extraction or
registration, are done synchronously on the Web-Server by the Short Task Module. Tasks
that are selected to run on the Small Task Modules must be brief, no longer than a few
minutes in duration, so as to keep the Web-Server responsive.
The interface provides a uniform approach to all forms and data tables. For example,
becoming familiar with uploading MRIs and viewing uploaded data provides insight into
uploading other modalities as well. Figure 3-1 shows the MRI upload form, which
contains fields for Record ID, Date, and the MRI file. Figures 3-2 and 3-3 display the
PET and DTI upload pages, respectively. The PET and DTI uploads require an existing
MRI to be processed. The PET upload form provides an option to upload a previously
registered PET.
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Figure 3-1: MRI upload form.

19

Figure 3-2: PET upload form.
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Figure 3-3: DTI upload form.
The Clinical form takes a CSV file with any number of rows and columns. NWSI only
requires that the fields "MRI_SITE_ID" and "SUBJECTID" be present. Upon upload, the
fields can be linked to the correct MRI record using the MRI_SITE_ID column. NWSI
uses a number of fields to display subject information throughout the site. The user can
map these fields to the ones present in the uploaded CSV. Figure 3-4 shows the clinical
data upload form, and Figure 3-5 shows an example of the field mapping. The design of
the clinical form allows uploading arbitrary clinical data to the interface.
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Figure 3-4: Clinical data upload form.

Figure 3-5: Field mapping.
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3.2

NWSI Hardware Architecture

Virtual technology, VMware ESXI 5.5 with SAN (Storage area networks) and HPE MSA
P2000 G3 Modular Smart Array Systems are used to host the NWSI Web-interface’s and
the replica servers. The cluster-aware infrastructure has two ProLiant DL 380 G7, with 2
CPUs x 3.332GHz, and 147 GB of RAM (Each), forming a centralized pool of resources
that is used to create virtual machines (VMs) which run their own operating system.
Figure 3-6 illustrates the virtual architecture.

Figure 3-6: Virtual Architecture.
The Web interface runs on a Virtual Machine (VM) running Ubuntu 14.04.5 LTS (Trusty
Tahr), Apache (2.4.16), PHP (5.5.28), and MySQL (5.6.26.) and is managed by Drupal 7
(latest version). The replica servers are two VMs running on Centos (6.6 el6.x86_64.)
with FreeSurfer (v5.3.0 16), each configured with 8 cores CPU and 16GB of RAM. The
processing time for a single MRI is from 8 to 12 hours; however, as many as 16 MRIs
can be processed simultaneously, using 2 replica servers with 8 cores each. PETs and
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DTIs are processed in fifteen and ten minutes, respectively. The use of a virtual server
environment adds availability, security and scalability to the Neuroimaging WebInterface application.

Figure 3-7: Architecture of the NeuroImaging Web Interface System.
Furthermore, new VMs can be added to the current design to increase the capability and
performance of the system. Replica servers can reside in a private cloud or the Internet,
as long as files can be securely copied between them and the web-interface. The webinterface can be accessed anywhere in the world with a fast Internet connection and a
browser. It is both device and operating system (OS) independent. The Drupal Theme is
responsive and tablet/phone friendly. Figure 3-7 above shows the architecture of the
neuroimaging web-interface system, wherein the user interacts with the Web Server
through the Web browser. Results from completed tasks are readily viewable. New tasks
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are sent by the Work-loader, to an available Replica Server, which sends the completed
task to the Post-Processing Core, from which new values are entered into the Database
and raw and new images are stored on the File System. Registration, Brain Extraction,
and other smaller tasks are processed on the Web-Server by the Small Tasks Module.
3.3

Image Viewer

Papaya, developed by the University of Texas Health Science Center at San Antonio, is a
powerful open source, interactive, JavaScript based image viewer incorporated within
NWSI. The web-interface accepts the three most common medical image formats as
input: single and multi-frame DICOM, ANALYZE, and NIfTI [18], but converts all files
to NIfTI, which is versatile, more compact and widely used. It should be noted that some
supporting software, such as FSL [19], only accepts NIfTI as input.
The version of Papaya in NWSI has been modified to display FreeSurfer labels and
custom color tables. The Web Interface is also capable of displaying specific color-coded
FreeSurfer regions, whole brain segmentation, interactive surfaces, PET, fMRI and DTI
images. As part of our processing pipeline, all image files are registered to the structural
MRI scan, making it possible to display several modalities as layers in the same viewer.
Among the tools embedded on the web interface and available to the user by Papaya are
color selection, a measuring tool, axis viewer, and image transparency modification, all
of which are standard in many other viewers. The user can display these images online
without having to save any files to the local hard disk. See Figures 3-8 and 3-9 below for
illustrative examples.
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Figure 3-8: Interactive viewer, showing surface reconstruction and anatomical MRI.

Figure 3-9: Image shows MRI, DTI and PET cross sections,
as shown by the Papaya viewer.
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Furthermore, the ROI explorer page displays a color-coded segmentation of FreeSurfer
regions. This is especially useful for researchers who are not familiar with FreeSurfer
labels but are familiar with human brain anatomy. Pertinent information can be visualized
by clicking on specific regions to scrutinize what different regions reveal. See Figures 310 and 3-11.

Figure 3-10: ROI Explorer: visualizing FreeSurfer Segmentation.
By default, all regions are shown.
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Figure 3-11: ROI Explorer: showing the left and Right Hippocampus and Amygdala.
3.4.

Visual Rating Platform

The gold standard for Amyloid PET rating is visual ratings. Expert raters inspect the PET
images and catalog them into positive, negative, or intermediate. When performing an
experiment, the raters will (1) look at the PET images, (2) rate each individual image, (3)
and record these values into a table. These recorded values will then have to be sent to
someone who will analyze them. This process creates many issues regarding the logistic
of people located in different parts of the city, or different parts of the world, looking at
these images with their own viewer (not necessarily the same viewer for all raters),
saving these values into a Word or Excel document, and sending the values to the
processing expert. There is also the image display normalization issue, as explained in

28

section 4.8), where users will have to adjust the image to account for flares outside the
brain within the limitations of their image viewer of choice.
NWSI provides a system to rate PETs. Images are presented to all users using the same
normalization, in the same viewer, and the results are collected and stored in the same
format. Furthermore, an interface was built for the processing expert to either export the
data or process the data within the NWSI platform.
NWSI provides a form to create PET rating projects. These projects can be enabled or
disabled, which mean whether or not they will be shown to the raters. They also contain a
page size field (indicating how many PETs will be presented to the rater at each iteration),
and a list of PET ids to be rated. The creator of the projects has control over how large
the dataset presented to the user is. See figure 3-12.
Once a project has been created and enabled, it will show in the rater’s interface. Raters
can select the project and rate the images. Figures 3-13 and 3-14 show the rating interface.

29

Figure 3-12: PET rating configuration form.

Figure 3-13: Project selection as displayed to raters.
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Figure 3-14: PET rating interface and individual PET to rate.

Finally, the processing expert can export the values and analyze them using a statistical
software, or simply use the statistics provide by the interface. NWSI calculates the Fleiss
Kappa, which is a common measure to compare ratings by multiple raters: interrater
reliability. It is also possible to measure intra-rater reliability by creating projects that will
be rated more than once by the same rater at different times.
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3.5.

SVM Classification Interface

The classifier, based on the libSVM (3.20) library [20], is accessible to the user as a form
in the website’s interface. The interface is simple yet provides many options to the user.
The SVM algorithm builds a model from a set of training samples by mapping an ndimensional array of vectors to an n-dimensional space and finding a hyperplane that
separates the classes. It is a type of supervised learning, in which the training data is
labeled. By default, SVM performs a linear classification, but it is possible to perform
non-linear classifications by employing what is known as the “kernel trick”. The SVM
classification provided in the form allows selecting a linear kernel, or a Radial basis
function kernel (RBF). RBF kernels at times perform better than linear kernels, but they
typically don’t scale well to large training samples or a large number of features. Features
refer to how many dimensions the n-dimensional input space has for classification
purposes, which could include structural, functional and neuropsychological measures,
among others.
The form, shown in Figure 3-15, provides an option to select the classes: Control (these
are subjects labeled as cognitively normal), non-amnestic MCI (naMCI: subjects with
mild cognitive impairment but no memory related symptoms), amnestic MCI (aMCI:
subjects with memory loss related symptoms), and AD (subjects with a diagnosis of
Alzheimer’s disease). Only two of the classes can be selected. Implementing an SVM
algorithm with more than one class is possible but given the subtle differences in brain
regional volumes that naMCI and aMCI subjects have compared to the cognitively
normal group, having two classes at a time performs better than in multiclass separation
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algorithms, although the advent of new machine learning algorithms could prove
otherwise.

Figure 3-15: Classifier form.
The Scaling must be selected next. Scaling makes each dimension have zero mean and
unit variance. It prevents attributes with a larger range to dominate the classification as
kernel values depend on the inner product of the vectors. Our method provides two types
of scaling: Linear, in which the values are in the interval [0, 1], and unit variance scaling,
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in which each value is replaced by the difference from the mean, divided by the standard
deviation. We found that both scaling methods work well and provide similar results.
Finally, the user must select the data features to use: the cortical volumes, hippocampal
subfields, cortical volumes, thickness average, and surface areas. Each of the sets of
regions is related to AD to some extent, and they are also related to each other. For
example, a large regional volume will have a large surface area. We found that the
hippocampal subfields (a FreeSurfer’s segmentation of the hippocampus), and subcortical
volumes provide a better separation of the data, as presented in the results below. Given
the regions that AD typically affects, although this result was expected, it was worth
validating.
Other options in the form provide additional configurations. For example, the values can
be (1) corrected for intracranial volume (ICV): regional brain volumes measurements are
corrected for variations in head size. (2) Use MMSE [21]: include the MMSE score in the
classification, although not encouraged since MMSE is initially used at baseline, to see if
the results have merits with and without inclusion of MMSE. (3) Balance data: when
selecting the input select the same number vectors for both classes. (4) Feature selection:
select features that are more relevant to the classification, based on their P-score. Feature
selection is reported to improve the performance of classification algorithms, but we
found that while other classification algorithms might be susceptible to the type of
features selected, feature selection was of little effect in our SVM implementation.
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3.4.

Data

3.4.1. The 1Florida ADRC
NWSI was piloted using a database of MRI, and amyloid PET images obtained from the
Alzheimer’s disease Research Center (the 1Florida ADRC). For this pilot project,
currently 303 structural MRI, 45 18F-Florbetapir PET scans, and 168 18F-Florbetaben
are available from the 1Florida ADRC.
MRI images were obtained using a Siemens Medical System Skyra 3 Tesla Scanner with
Software version: “Syngo MR E11”. Coil: “Siemens Head/Neck 20”. The Scanning
Sequences used was: 3D T1-W Magnetization-Prepared Rapid Gradient-Echo
(MPRAGE.) Sagittal, three dimensional images with resolution of 1 mm (~12 min., TR =
2150 ms, TE = 4.38 ms, TI = 1100 ms, 160 slices, 1x1x1 mm3) obtained from
approximately 1 cm left of the skull to 1 cm right of the skull, allowing room for spatial
reorientation along defined anatomic coordinates.
DTI scans were obtained from the same MRI scanner. The sequence takes approximately
5 minutes (TR = 7300ms, TE = 84 ms matrix: 128x128, slice thickness =2.2 mm, number
of slices = 64, iPAT factor = 2). DTI scans were used to measure radial, axial, and mean
diffusivity as well as fractional anisotropy (FA).
PET images were obtained from a Siemens Biograph 16 Hi-Rez, 2006, with software
version: “SYNGO CT 2009E”. Image matrix 128x128, Zoom 2, Slice thickness 3.0 mm,
Post reconstruction Filter: 3.0mm Gaussian. F18-Florbetapir scanning entails intravenous
injection of 10mCi of tracer, a 50-minute period for tracer uptake, followed by 20-minute
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scan period for image acquisition. For F18-Florbetaben imaging the dose injected was
8mCi, the uptake period between injection and image acquisition was 90 minutes and the
image acquisition period was 20 minutes.
3.4.2. ADNI
Data used in the preparation of this article were obtained from the Alzheimer’s disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was launched in
2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner,
MD. The primary goal of ADNI has been to test whether serial magnetic resonance
imaging (MRI), positron emission tomography (18F-Florbetapir PET), other biological
markers, and clinical and neuropsychological assessment can be combined to measure the
progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD).
MRI scans were acquired from 1.5T or 3T scanners at multiple sites across the United
States and Canada using MP-RAGE/IR-SPGR protocols for volumetric analyses. F18Florbetapir PET acquisition time was 50 minutes following administration of 370 MBq
(10 mCi) bolus injection of F18-Florbetapir, over a 20-minute scanning period, the
images were reconstructed immediately afterwards. Details of MRI and F18-Florbetapir
PET imaging data acquisition are available in the ADNI website.
3.4.3. GAAIN (Centiloid Project)
Data from GAAIN was made available by the researchers of the department of Molecular
Imaging & Therapy in Melbourne Australia. This data was used in the Centiloid [22]
project (CL). The centiloid method expresses SUVR values in a universal scale. In their
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paper [23] the researchers use this data to derive the equation to convert uptake values
from 18F- Florbetaben to CL values. They used 35 subjects that were scanned (MRI and
18F- Florbetaben PET): ten cognitively normal under 45 years old, and 25 AD, MCI, and
frontotemporal dementia subjects. MRIs were obtained from a Siemens 3-T Trio camera
with 1 × 1 × 1.2 mm voxels, and the PET scans from a Philips Allegro PET camera in 3D
mode and processed with rotating Cs-137point source attenuation correction. This data
was uploaded to NWSI to validate 18F- Florbetaben SUVR calculations.
Once the SUVRs were determined, the following formulas were implemented. For
Florbetaben, the centiloid formula implemented and cross-validated with [24] is:
CLunits = 153.4 × SUVRFlorbetaben − 154.9

(3.1)

On the other hand, for Florbetapir, the centiloid formula is:
CLunits = 183.07 × SUVRFlorbetapir – 177.26

(3.2)

Equation 3.2 could not be validated since they do not show the results they have obtained.
All the conversion does is move a numeric value into another one, with no observable
visual change, but these two formulas consolidate the scale for the images taken with
these two different imaging tracers.
3.4.4. Baptist Health South Florida
Subjects from Baptist Hospital were scanned with a Philips Medical Systems, NM
Division, protocol Brain Perfusion Scintigraphy. Scanning protocol: Trans AC. Slide
thickness 3.195mm, Image Matrix 128x128. Contrast: FDG – fluorodeoxyglucose.
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3.4.5. Nicklaus Children's Hospital
Subjects from Nicklaus Children's Hospital were scanned with a GE Medical Systems,
model: Discovery ST. Scanning protocol: PET AC 3D Brain. Slide thickness 3.27mm,
Image Matrix 128x128. Contrast: FDG – fluorodeoxyglucose.
3.4.6. SVM Classifier Data
The classifier was linked to ADNI Data. ADNI provides a dataset for AD research. The
input features were selected from the ADNIMERGE document, available for download
on the LONI site. We also tested the algorithm with data from the Wien Center for
Alzheimer's Disease and Memory Disorders at Mount Sinai Medical Center, Miami
Beach. Our datasets are as described in Table 3-1. Volumetric measurements in ADNI
data were obtained using FreeSurfer 5.1, processing the MP-RAGE protocol sequence,
with 1.5 Tesla scanners. The
Wein Center data was obtained from T1 weighted MP-RAGE scans, from a Skyra 3
Tesla scanner. The results were processed in FreeSurfer 5.3 at the Center for Advanced
Technology and Education (CATE), Florida International University. All subjects went
through similar visual quality control processes.
Table 3-1: Datasets Considered.

Class
Normal
Na-MCI
a-MCI
AD

ADNI
139 subjects
220 subjects
108 subjects
76 subjects
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Wien Center
127 subjects
55 subjects
68 subjects
61 subjects

3.5.

Cost Analysis

NWSI scalability allows for a large number of additional replica servers. The basic
requirement is two servers: one hosting the web interface, and the other for processing
images. This setup was the initial prototype and it worked well for small batches of less
than 20 or 30 sets all uploaded at the same time. The cost of maintaining two dedicated
servers is low: services such as Godaddy.com provide each server from $69.99 per month
for a dedicated Linux server. The current prototype is installed on a distributed system
located at Florida International University. This type of setup is more secure and easier to
manage, having a larger price tag. FIU paid $62,000.00 including hardware and software
licenses. If all the resources are utilized the FIU setup can service many requests, with the
capability to process hundreds of MRIs and PETs per day. The prototype only uses 3
servers from up to 15 servers which can be created on this distributed system with 8 cores
and 32GB each.
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4.

4.1

Neuroimaging Capabilities

Volumetric and Cortical Thickness Calculations from Anatomical MRI

The basic functionality of NWSI depends on using FreeSurfer to reconstruct cortical
surface models (gray-white boundary surface and pial surface) from structural MRIs and
to output regional cortical and subcortical volumes, cortical thickness, and other values
derived from input image segmentation (see FreeSurferWiki (fswiki) for a complete list
of such measures). FreeSurfer also outputs image files that define the segmentation and
replaces intensity on these files by numeric values representing the segmented regions.
These files are used in the calculation of PET Standardized Uptake Values (SUV).
NWSI processes all structural MRIs on a local server, rather than using the option of
uploading existing FreeSurfer values, because it was determined on testing the system
that FreeSurfer results were affected by the OS version adopted, even when the same
FreeSurfer version was used [25]. This outcome serves as a measure of caution,
especially for comparative studies and analyses. FreeSurfer specifies in the fswiki that
when processing a group of subjects, it is essential to use the same FreeSurfer version on
the same OS platform and vendor, because certain OS level libraries might affect the
results. As new replica servers are added to the system, it is imperative to test them
before deployment to make sure the results are validated against established ones.
An important issue, which can be resolved by NWSI, is the merging of data from
different sources, which is a non-trivial task due to factors such as scanner bias, scanner
field strength, among others [26]. This problem is best addressed by processing all values
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with the same hardware and software, once enough data from different sources is present
on the server. Results from subjects from one institution (e.g., control subjects) can be
merged with subjects from another institution, downloaded and tabulated in a format.
Figure 4-1 shows a sample comma separated values output.

Figure 4-1: Sample Tabulated Output for Subcortical Regions.

4.2

PET Imaging Analysis with 18F-Florbetapir PET / 18F- Florbetaben

Regional quantification of regions of interest (ROI) is still defined manually, but
automatic Standardized Uptake Value ratio (SUVR) calculations and segmentation of
PET images have become the gold standard [4]. NWSI implements several PET analysis
pipelines for FDG and 18F-Florbetapir images. Prior to uploading a PET scan, a
structural MRI must already exist in the system; the user is presented with a form in
which an existing MRI must be selected. After the PET scan is uploaded, it is copied to
one of the RSs for processing and can be accessed through a form that lists all uploaded
records, as shown in figure 4-2. This form also contains graphs showing the distribution
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of all PET scans uploaded by the user as in Figure 4-3. Once a PET scan is processed, it
can be displayed on the interactive image viewer, as shown in Figure 4-4 and Figure 4-5,
and then quantitative data can be downloaded from the PET scan page, as shown in
Figure 4-6.

Figure 4-2: Page Listing PETs in the Account, with Links to the MRI used as reference.

Figure 4-3: Graph Showing the Distribution of all Uploaded 18F-Florbetapir PETs.

42

Figure 4-4: Higher Concentration of 18F-Florbetapir Shown in Warmer Colors of the
Spectrum Look Up Table (LUT).

Figure 4-5: PET Image Overlaid with White Matter Surface (shown in white) and Gray
Matter Surface (shown in black). The selected region’s SUVR and Name are shown.
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Figure 4-6: PET Results Page Showing All SUVR Values, Links To Download Tabulated
Results, and a Graph Comparing the Result to he Averages Determined in the System.
It is essential that the PET image is co-registered to the anatomical MRI because all
calculations depend on how closely the anatomical regions of the two images overlap. A
particular challenge for aging and AD and other neurodegenerative diseases is atrophy
correction. It should be indicated that co-registration to MRI images largely reduces
artifacts related to atrophy. The current implementation aligns the images using FSL. The
alignment uses 12 degrees of freedom (3 translations, 3 rotations, 3 scalings, and 3
Skews/Shears). Then, a so-called custom R software opens the co-registered PET and the
FreeSurfer segmentation volume, performing a voxel by voxel analysis of the intensities
of the PET file, and accumulating values per anatomical ROI. The average over a region
provides the SUVs, as given in Equation (1. The SUVR are then calculated by dividing
the SUV by a region of reference (SUVRG) as expressed in Equation 2. Larger regions,
aggregated from FreeSurfer sub-regions can also be calculated. SUVR, for combined
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FreeSurfer regions (CB), are calculated by a volume weighted average of previously
calculated SUVR as described by Equation 3.

(4.1)
Where

is the total number of voxels in

,

is the value of voxel k in

in PET image.
(4.2)

(4.3)

Where the CB consists of m ROIs,

and

are the corresponding SUVR and

volume of ROI sub-regions, respectively.
Current literature mentions the merits of using an assortment of reference regions, such as
the total or eroded subcortical white matter, the brain stem, the whole cerebellum, or the
cerebellar white matter [27]. SUVR results, normalized by the whole cerebellum, have
been validated using values reported by ADNI. NWSI also calculates SUVR using
unilateral or bilateral cerebellar white matter. The values can be exported on tabulated
files.
PET imaging with 18F-Florbetaben also measures global cortical amyloid load and uses a
similar processing pipeline to 18F-Florbetapir images. However, statistics and results on
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NWSI are reported separately to avoid bias. Studies have shown that there are no marked
differences in the diagnostic accuracy of the amyloid binding ligand [28].
4.3

FDG-PET in Epilepsy

PET imaging using Fluorodeoxyglucose (FDG), labeled with a positron emitting tracer
[Fluorine-18], or FDG-PET, is used to measure regional glucose metabolism, which is
strongly correlated to, and widely used to measure regional neuronal activity in the brain
[29]. To study epileptic conditions using FDG-PET, in combination with structural MRI,
regional SUVR is calculated using the cerebellar white matter, or the whole cerebellum,
as a reference region [30]. In studying epilepsy, special consideration needs to be given to
identifying focal conditions in one hemisphere and to account for surgical resection of
regions in the brain. The FDG-PET pipeline in NWSI allows a choice of several
reference regions, including the whole cerebellum, the cerebellar white matter, the
average of all bilateral cortical regions (global cortical SUV), or all regions for a single
intact hemisphere (in subjects who have had a prior resection in one hemisphere.
The PET images are superimposed on MRI brain scans for defining the underlying
structure and brain regions which have been resected. Regional SUVR is derived similar
to the procedure for amyloid PET scans, and asymmetry in corresponding bilateral
regions is calculated by dividing the difference in SUVR among corresponding bilateral
regions by their sum and multiplying by 100%, as shown in Equation 4. Reference
regions are not required in this calculation of asymmetry; a difference of 10% or greater
between bilateral regions is typically considered to be consequential.
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SUVRROI i − SUVRROI i

R

SUVRROI i + SUVRROI i

R

L

Dif ROI i =

and
4.4

L

are the SUVR of

× 100%

(4.4)

in the left and right hemisphere.

Diffusion Tensor Imaging (DTI)

DTI analysis on NWSI is still under development. Currently, the DTI is obtained by
executing the DTIFit FSL tools on an anatomically co-registered Diffusion-Weighted
Image (DWI) that has been corrected for Eddy currents. The DTIFit program fits a
diffusion tensor model at each voxel. The resulting DTI eigenvalues and eigenvectors can
be shown on the web interface viewer modulated by the Fractional Anisotropy (FA)
image. As these images are co-registered to the anatomical MRI, further analysis can be
done to obtain numeric values for anatomical ROIs. See Figure 4.7.

Figure 4-7: Sample Processed AD DTI. V1 Modulated by FA.
Colors Represents Direction of Water Movement: Green is front to back.
Blue is head to foot. Red is left to right.
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4.5

Data Conversion

There are currently three main image formats for storing medical images. Digital Imaging
and Communications in Medicine (DICOM), ANALYZE, and Neuroimaging Informatics
Technology Initiative (NIfTI). The DICOM format was introduced in the 1980s, and has
gone through several revisions since, to arrive at the current standard. It is the preferred
format scanners use to save or store images.
NWSI can take DICOM as input in several of the forms. The ANALYZE format (also
known as ANALYZE 7.5) was created by the Mayo Clinic as the default format for their
Analyze software. The ANALYZE format lacks consistency regarding orientation of the
image, making it unsuitable for research. NWSI provides support to convert from
ANALYZE to NIfTI. The NIfTI format, introduced in 2003, which was developed to
replace the ANALYZE format, is the preferred format among researchers. It addresses
the issue of spatial orientation. NWSI uses predominantly the NIfTI format because it
makes forms simpler and uploads consist of a single file.
The Data Convert (DC) form contains two menu tabs, each indicating either ANALYZE
or DICOM, and contains fields for uploading a file and recording ID. Upon submitting
the form, the file is converted and saved in the file system in NIfTI format and is stored
in the Converted MySQL table. The converted file can be downloaded by the user
immediately after conversion, or anytime later. The Conversion algorithms call functions
in FreeSurfer and FSL, depending on the input. It also decompresses the image file, if it
were compressed. Compression is used to save storage space, but many software
packages like FreeSurfer do not take compressed DICOMs as input. The DC tool
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produces a standardized NIfTI file that can serve as input to most processing software,
including FreeSurfer, SMP8, and FSL. See Figure 4-8 for a screenshot of the Data
Convert form.

Figure 4-8: Data Convert Tool.
4.6

The Co-Registration Tool (CRT) and Apply Matrix forms

The CRT Tool allows co-registering one brain image to another, from similar or different
modalities. This form uses FSL tools to align the images and exports many of the options
to the user, such as: (a) extract the brain from source images before registration, and (b)
define the degrees of freedom, cost function, or angle to rotate the images. For most of
the AD data processed in NWSI, default FSL registration parameters work well. However,
some images have noise or artifacts and cannot be used for automatic registration. CRT
allows the user to find the registration parameters for individual images before they are
uploaded to other processing pipelines. Current and previous results can be inspected in
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an embedded viewer. Co-registration is the main step to many processing pipelines,
especially for multimodal imaging. Many algorithms, calculating multimodal values,
depend on a perfect registration (overlay) of both images. Figure 4-9 shows the CRT
form.
The Apply Matrix Tool applies an existing FSL matrix transformation to an image. A
matrix transformation is defined within FSL as the transformation parameters. It is a text
file which saves the 12 transformation parameters applied in the registration process:
rotation, scaling, skew, and origin (3 coordinated for each).

Figure 4-9: Co-registration Tools: Brain Registration Form.
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4.7

Brain Extraction Tool (BET)

The BET tool interfaces with FSL to extract the brain in a medical image. All command
line options are exported to the interface. Extracting the brain is the first step in many
processing pipelines. Images that were cropped at scanning time cannot be registered to
complete images because the complete images have extra information that cannot be
matched. During the registration process, it is sometimes required to extract the brain
from both images, to later apply this registration matrix for the whole image to be
registered.
4.8

Image Display Normalization

NWSI provides several views of the same data. MRI results contain the ROI explorer, the
Segmentation, T1, Brain, and a surfer viewer. These images come from FreeSurfer, and
the voxel values are normalized between 0 and 255 for an 8-bit resolution. NWSI leaves
PETs in their original resolution because normalizing the values will impact the SUVR
calculations. PET images sometimes contain very high voxel values in non-brain areas.
These higher values skew the range of the intensity values and lower the contrast within
the brain. Figure 4-10 shows a sample PET with these flares of brightness around the
neck.
These brighter areas are unimportant and play no role in the calculation of SUVR values.
NWSI uses the maximum and minimum value within the brain to normalize the PET
image at display time. The new image, as shown in Figure 4-11, discerns the gradient of
amyloid deposition in the brain much better. This normalization is done automatically.
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Figure 4-10: PET Shown in the Papaya Viewer without Correcting
for extrema values Inside the Brain.

Figure 4-11: PET Shown in the Papaya Viewer after Correcting
for Extrema Values Inside the Brain.
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4.9

White Matter Contours on PET images

Another contribution of the NWSI web interface is in utilizing white matter contours to
aid in PET visual ratings. The gold standard for visually rating PETs is to display them in
grayscale and visually assessing how much brighter are the cortical regions in contrast to
white matter. The problem with that process is that it requires knowledge of the anatomy
of the brain, and keen visual perception gained through years of experience of the visual
rater. Figure 4-12 (right) shows a sample PET with the white matter contour. The red
circles mark regions where the tracer has spread to cortical regions. Without the white
matter contour, it will be really difficult to rate this PET without an understanding of the
brain anatomy.

Figure 4-12: Left is the PET Image without White Matter Contour, and Right Image is
the Same PET with the White Matter Contour; Red Circles Indicate Areas where the
Tracer has Spread to the Cortical Regions.
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The white matter contour helps experts and non-experts alike rate more effectively the
PET scans. Figure 4-13 shows the full Papaya viewer, with the white matter contour,
regional SUVR value, and region name. With this information at hand, it is possible to
know that in the rostral middle frontal region the SUVR is 1.49 (higher than the threshold
for a Florbetaben and Florbetapir PET scan), and also that the tracer has spread to this
area.

Figure 4-13: Full Papaya Viewer with White Matter Contour, showing SUVR Value, and
Anatomical Region Name.
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4.10

Heat maps

One of the advantages of NWSI is the visualization component. Heat maps are a
powerful way of inspecting data. Essentially, values are assigned to FreeSurfer regions,
and a gradient of colors is overlaid on a T1 images representing these values. In a twocolored heat map (i.e.: Blue/Red), lower values will be bluer, while higher values will
contain more of the red color. These values represent a specific measure, for example
regional atrophy, or SUVR value. They could also group FreeSurfer regions into larger
sets (such as frontal, parietal, etc.) and represent each larger region with the same color.
A form was developed to display regional information as heat maps. The form lets the
user select an MRI from a list and use the output from an excel document to color the T1
image. The form is built with JavaScript, allowing a responsive and interactive interface.
The form is capable of representing any set of measures as a heat map, as long as such
measures can be converted into specific regional values. For illustrative purposes, Figure
4-14 represents the cortical and subcortical volumes. The left cortical regions were
assigned a value of 1; the right cortical regions a value of 4. The subcortical regions were
assigned values 2 (left) and 3 (right), respectively.
Figures 4-15 and 4-16 show visualization examples of the SUVR values in an AD patient
and control subject, respectively. Subjects are classified as positive or negative SUVR
depending on the amount of amyloid load that has deposited into certain cortical regions.
Figure 4-15 has little color contrast between cortical and subcortical regions. This
indicates that the depositions of SUVR in cortical regions are similar to the ones observed
in the white matter.
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It is also noticeable that frontal regions have lower contrast with their surrounding white
matter regions, while occipital regions have more contrast. This is consistent with the
way amyloid deposits in AD. Figure 4-16 has a higher contrast between cortical and
subcortical regions, which is indicative of lower amyloid depositions in the cortical
regions.
Figure 4.17 shows another type of heatmap focusing on the cortical volumes, where an
expert could visualize which regions have atrophied. Each region represents its own
cortical volume. Regions colored with deeper shades of red have larger volumes. For this
Figure a Yellow/Red color map was used instead.

Figure 4-14: Heat map of Cortical and Subcortical of Right and Left Hemisphere.
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Figure 4-15: Heat Map of AD (Amyloid Positive) Subject.

Figure 4-16: Heat Map of Control (Amyloid Negative) Subject.
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Figure 4-17: Represents the cortical volumes. Each region was assigned the value of its
volume. Regions colored with deeper shades of red have larger volumes. For this Figure a
Yellow/Red color map was used instead.
Given that the values modeled come from NWSI subjects, the heat maps can be created
for the same subject they were calculated for. The heat map form allows modeling the
properties on the same brain, even if the values come from different subjects. This
provides a common platform for visualization. This makes it possible to model properties
from subjects obtained from other sources (not in NWSI). Regions with a value of -1 will
not be displayed; that way only selected regions will be visible.
The current implementation does not store heat maps on the server. The users of the
interface can store these reusable heat maps in excel at their local computers. Besides the
colors, the viewer also displays the region name as the mouse hovers over the region.
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In epilepsy, differently than for AD, the goal is to detect the epilepsy focal region in the
brain where seizures are thought to emanate from. We have studied the correlation
between PET/MRI-Volumes and epileptogenicity maps having been explored with
Electroencephalography (EEG). The significance of the results suggests that interictal
FDG-PET/MRI-Volumes and ictal EEG activity may share some common underlying
pathophysiologic mechanisms of ictogenesis, and by combining all features may help to
identify the seizure-onset zone with a higher accuracy. Unbalance in brain regions
originated by activity, as measured through PETs, or atrophy, as measured by volumes,
can be visualized as heat maps by coloring the regions by SUVR values or regional
volumetric measurements.
Figure 4.18 below shows a heat map of volumetric measurements. By comparing the
difference in color in regions on the left and right hemispheres, asymmetry can be
evaluated. The volume of the superior temporal lobe is smaller to the left when compared
to the right. There is an evident asymmetry between these 2 homologous regions. These
homologous regions also show asymmetry when SUVR values are compared. These
results validate the 3D source location of this patient since the left temporal region is the
presumed epileptogenic region, as shown in Figures 14.19 and 14.20.
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Figure 4-18: Slice of a heat map Epilepsy subject showing asymmetry between
homologous regions. The volume of the left temporal lobe is smaller when compared to
the right.

Figure 4-19: The 3D source solution (b) is also indicating the superior temporal region as
the source of the seizure; the volume asymmetry (a) is also evident in the same region.
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Figure 4-20: Volume of the Superior frontal region (a) also shows asymmetry and it also
coincides with some 3D results (b).

4.11

Image Restoration

4.11.1 Introduction
Structural MRI Images are processed to extract features such as regional volumes, area
surfaces and cortical thickness. Algorithms that process these images, such as FreeSurfer
(an open source software developed by the Laboratory of Computational Neuroimaging),
perform better if the images are acquired free of noise and artifacts [31]. Unfortunately
during the acquisition of the images many avoidable or unavoidable errors can occur that
translate into artifacts [32]. One common artifact is aliasing: when the FOV (field of view)
is smaller than the part of the body scanned, causing a wrap-around of the body part
outside the image [33]. The aliasing artifact also causes shading at the edges of the image
in the phase-encode direction. Small FOV decreases the duration of scanning. When
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scanning the brain many technicians chose the smallest possible FOV to save time.
Aliasing artifact can be corrected by increasing the FOV at the time of the scan. If the
scan cannot be repeated because of patient follow-up issues, methods must be developed
to deal as best as possible with these corrupted images.
Alzheimer’s disease does not reflect prominently in the occipital regions [34], but an
underestimation due to shading in the occipital area will cause an underestimation of
brain size, or intracranial volume (ICV) [35]. ICV is an important metric in inter-patient
studies, often used to correct for brain size. As a consequence, this study proposes a new
method to restore the image with shading artifacts. The shading of the occipital regions
reduces the range of the values, causing pixels with different values to be equal. There is
no way to restore the image and separate those equal pixels since the information is lost.
N3 and N4 algorithms [36] (nonparametric non-uniform intensity normalization) were
tried, but could not correct the strong signal loss. Enhancing contrast methods were tried,
but they were found to be time consuming given the number of images to process [37].
Included in this implementation are 207 volume MRI images (out of a total of 223) that
displayed occipital shading but were acquired with the Skyra MRI machine. All were
acquired as part of the 1Florida ADRC cohort, taken from 2016 to 2018. The proposed
image restoration method begins by selecting a random sample of 25% of the images and
extracting the brain with the Brain Extraction Tool (BET). The brain extraction is
visually inspected to make sure it contains the shaded area. BET can be parametrized to
extract more, or less of the brain matter. These extracted brains are quality controlled and
processed in FSL FAST (FMRIB's Automated Segmentation Tool). FAST is an
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automated algorithm that creates a segmentation of the brain into white and gray matter,
outputting also the average pixel values for white and gray matter. Then, starting from the
first slide at the edge, the brain is traversed until a slide is found that is within 5% of
these averages (each slide is treated as mixture of Gaussians, and the histogram’s
intensity ranges are scaled). This slide indicates where the shading artifact dissipates.
Then, starting on that slide we go back to previous slides recording the averages until we
exit the brain. These values are used to create a model describing the shading. Experts in
the field of image processing know full well that image restoration is perhaps the most
challenging of tasks as we always struggle to define all the parameters of the transfer
function or of the degradation process that led to a less than perfect image acquisition
process. Hence, as we cannot achieve full restoration, it was deemed sufficient to restore
intelligently the pixel intensities enough for FreeSurfer to extract the whole brain and
overcome the presence of shading. A java Application was developed that uses the
parameters modeled (threshold, start and end slides, white matter, gray matter averages).
The intensity in the shaded areas is increased according to the model, and the image is
saved and re-processed by FreeSurfer.
Medical images often contain artifacts: Anomalies of the visual representation of the
image. These artifacts are features that were not present in the original image and prevent
algorithms from correctly interpreting and processing the images. The ADRC data was
plagued by wrap-around artifacts that caused shading in the frontal and occipital regions.
Some images, where the aliasing overlapped the main central image were discarded, see
Figure 4.21. Others can be corrected, since only shading was present, see Figure 4.22.
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Figure 4-21: Aliasing Artifact Overlapping the Occipital Region. This Image is not
Usable as the Two Signals Overlap Resulting in Erroneous Results.

Figure 4-22: Shading in the Occipital and Frontal Regions Prevent FreeSurfer from
Segmenting the Image Correctly. The Blue and Red Lines Represent the White and Gray
Matter Respectively.
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4.11.2 Problems arising from Shading
During image acquisition, once the signal loss darkens the image, the range of values is
altered. Once two pixels acquire the same value in the reduced range, they become
indistinguishable and cannot be restored to their original values. Luckily, most of the
shading was observed in the occipital area, which is not considered important in regions
prone to AD.
Nonetheless, to avoid any risk of faulty measurements, especially in estimating
intracranial volume (ICV), a method was created through the NWSI interface to model
the loss of signal and restore the images to an approximation of the original images,
allowing as a consequence FreeSurfer to register the whole brain and segment the whole
volume. Some underestimations will occur in the occipital cortical values that are
irrelevant to AD, but FreeSurfer will be able to see the whole brain and estimate the ICV
(Intracranial volume) correctly. Also, as the rest of the image remains unchanged
FreeSurfer will estimate the same volumetric values for the unaffected regions: such as
the Hippocampus and precuneus.
The ICV value is fundamental for experiments using volumetric regional values. Intersubject brain sizes are adjusted by dividing the regional volumes by the ICV. The ICV
value is not expected to change significantly for the same adult subject. Brains that are
atrophied will also keep the same ICV because the ICV is measured from the Dura matter
(the outermost membrane enveloping the brain).
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4.11.3 Methodology for Image Restoration
ADRC subjects that contained frontal and occipital shading with no overlapping aliasing
were selected and uploaded into the NWSI web interface in order to obtain the FreeSurfer
results. Figure 4.23 shows subject 1, where noticeable shading highlighted in green could
lead to an underestimation of the brain volume. The ICV reported by FreeSurfer was
estimated as 1277405.93 mm3.

Figure 4-23: Subject 1 Processed by FreeSurfer with Underestimated Brain Size (Shading
is Indicated by the region highlighted in Green). The Blue and Red Lines Represent the
White and Gray Matter, Respectively.
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To overcome such incorrect volume estimations, 25% of the images were randomly
selected and an image restoration model was created using the following steps:
(1) Extract the brain with the BET tool. Once the brain is extracted the skull is
removed, and the only intensities present in the image are associated to brain
tissue, as illustrated in Figure 4.24.
(2) Execute FSL FAST to estimate the BIAS field and white/gray matter
segmentations and related intensity averages.
(3) Find, from the last slide (stepping forward), the slide where the average of white
and gray matter intensity averages is within 5% of the value reported by FLS
FAST as can be observed in Figure 4.25. (This will detect the slide where the
shading artifact dissipates).
(4) Increase the brightness of the shaded slides until the averages are within 5% of the
expected intensities reported by FSL FAST. As the shading is gradual slides
closer to the edge will be darker.
(5) Find the minimum threshold that will increase the brightness of the brain, but not
the background (if the background values are increased a band will be visible in
the areas outside the brain.
(6) Average these values for all images and save the parameters.
(7) Perform steps 1-6 for the frontal region.
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Figure 4-24: Extracted Brain, with visible shading in the occipital region.

Figure 4-25: Slide where the Average Values of Gray and White Matter are within 5% of
the Ones Reported by FSL FAST.
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A Java application was developed to open the MRI image files and perform the changes
to all the images in a batch job. The new corrected images were uploaded to NWSI.
Figure 4.26 contains Subject 1, before and after the correction. Subject 1 was used as a
model because two other MRIs were present in the data base with the expected ICV. The
other two ICV values were 1375730.91 mm3 and 1387010.24 mm3, which are within the
expected error for intra-subject ICV values. The reported ICV of the corrected image is
1367832.66 mm3.

Figure 4-26: Subject 1 on the left with no correction, ICV= 1277405.93 mm3. On the
right Subject 1 with the corrections, ICV 1367832.66 mm3 (diff=6.6%) The red and blue
lines cover the whole brain volume. The blue and red lines represent the white and gray
matter.
4.11.4 Restoration and Dependence to Type of MRI Scanner
When the restoration model was applied to all MRIs that presented shading, we
discovered that the performance of the model was extremely good for all MRIs acquired
more recently with the Skyra MRI machine that was newly acquired at the Wien Center
for Alzheimer's disease and Memory Disorders at Mount Sinai Medical Center.
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Coincidentally, the same restoration model did not perform as well on those older MRIs
acquired through a different scanner (26 MRI volumes out of 207). To prove our point,
patient 110004 was processed using both restoration models, as can be observed from
4.27. The new ICV using Model 2 is 1369666.25147, while the previous one using Model
1 was 1367832.66104).
The new corrections improve the segmentation in the frontal cortex. Some regions that
were missing from the segmentation are now part of it. This might not seem like a
significant improvement, but those cortical regions are very thin, and any bit of it that we
account for could affect the results. This is especially true in the frontal cortex, as this
case has shown, that is deemed so important for AD classification and prediction.

Restoration Model 1-based Correction.

Restoration Model 2-based Correction.

Figure 4-27: Restoration dependency on Scanner Type: with older-MRI-based ICV
(Model 1) being ICV: 1367832.66104 and new ICV from the more recent MRIs (Model 2)
found to be increased to 1369666.25147 (diff=1.34%) The red and blue lines are the gray
and white matter.
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We determined that patient 110004 was not an extreme case in comparison to the other
16 scans acquired pre-Skyra, it is just because we noticed those missing cortical sections,
which are relevant in AD. But most of the other 16 scans should improve calculations of
the ICVs much significantly.
4.11.5 Merits of the Proposed Image Restoration Methodology
The proposed method partially restores the structural MRIs and allows for more accurate
estimations of the ICV measure. All the MRI images were obtained using the same
scanner and apparently under the same conditions, so the created model 1 was applicable
to all 207 MRI volumes. As we have demonstrated, this method can be modified to create
a different model (e.g. Model 2) which was created for the other 16 MRI volumes which
acquired using a different MRI machine and which has introduced different form of
shading.
FreeSurfer has a method that allows a user to create control points in the white matter in
order to increase brightness in the vicinity of the point. But this will mean that each
image will have to be opened and edited individually. Processing 207 images will
probably take a month or longer. The method proposed is capable of creating a model and
process the images in a few minutes, with no human interaction.
4.12 SVM Classification
While the SVM classifier was designed to be used with any dataset provided by the user,
we calibrated it and tested it with our datasets. Each experiment was iterated 50 times,
each iteration dividing the data in a new random pattern: Tables 4-1 to 4-4 below show
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the results of the experiments with the ADNI dataset for the different binary
classifications.
4.12.1 Control vs. AD, RBF Kernel, corrected for ICV
Table 4-1 shows the results from running the interface for Controls vs. AD, selecting
linear scaling, RBF kernel, and correcting for ICV.
4.12.2

Control vs. AD, Linear Kernel, corrected for ICV

Table 4-2 shows the results from running the interface for Controls vs. AD, selecting
linear scaling, linear kernel, and correcting for ICV.
4.12.3 Control vs. aMCI, Linear Kernel, corrected for ICV
Table 4-3 shows the results from running the interface for Controls vs. aMCI, selecting
linear scaling, linear kernel, and correcting for ICV.
Table 4-1: Control vs. AD, with RBF Kernel, Linear Scaling, correcting for ICV.

SV*

HS*

CV*

TA*

SA*

Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy

0.82
0.91
0.89
0.71
0.89
0.83
0.68
0.92
0.84
0.71
0.95
0.87
0.45
0.84
0.70

* SV: Subcortical Volumes, HS: Hippocampal Subfields, CV: Cortical volumes, TA: Thickness, SA: Surface Areas
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Table 4-2: Control vs. AD, with linear kernel, linear scaling, correcting for ICV.

SV*

HS*

CV*

TA*

SA*

Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy

0.81
0.91
0.88
0.76
0.89
0.84
0.69
0.88
0.82
0.73
0.93
0.86
0.55
0.81
0.72

* SV: Subcortical Volumes, HS: Hippocampal Subfields, CV: Cortical volumes, TA: Thickness, SA: Surface Areas

Table 4-3: Control vs. aMCI, with Linear Kernel, Linear Scaling, correcting for ICV.

SV*

HS*

CV*

TA*

SA*

Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy

0.65
0.80
0.73
0.66
0.80
0.74
0.61
0.75
0.69
0.53
0.74
0.65
0.50
0.67
0.59

* SV: Subcortical Volumes, HS: Hippocampal Subfields, CV: Cortical volumes, TA: Thickness, SA: Surface Areas
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4.12.4 Control vs. AD, Linear Kernel, corrected for ICV, and using MMSE
Table 4-4 shows the results from running the interface for Controls vs. AD, selecting
linear scaling, linear kernel, correcting for ICV, and using the MMSE score in the
classification.
Table 4-4: Control vs. AD, with Linear Kernel, Linear Scaling, correcting for ICV, using MMSE. * SV:
Subcortical Volumes, HS: Hippocampal Subfields, CV: Cortical volumes, TA: Thickness, SA: Surface
Areas.

SV*

HS*

CV*

TA*

SA*

Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy
Sensitivity
Specificity
Accuracy

0.91
0.95
0.94
0.83
0.92
0.89
0.83
0.94
0.90
0.84
0.98
0.93
0.82
0.93
0.89

* SV: Subcortical Volumes, HS: Hippocampal Subfields, CV: Cortical volumes, TA: Thickness, SA: Surface Areas

When classifying Control versus AD using the RBF kernel and correcting the data for
ICV, and in reference to Table 1, results show that accuracy and sensitivity are higher for
subcortical volumes and hippocampal subfields. These are expected as Alzheimer’s
disease is known to affect memory cognition centers that are located among the
subcortical regions, where the hippocampus is located. For cortical volumes, thickness
areas and surface areas, the results are less meaningful.
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When using the linear Kernel, as in Table 4.2, results indicate that the linear kernel
performs slightly better than the RBF kernel. Table 4-3 shows the classification of aMCI
vs. control. Subject with aMCI are considered to be potentially closer to developing AD,
and certain volumetric difference can be classified. However, the accuracy is much lower
than on the previous experiments; this is because aMCI patients don’t have the advanced
level of brain atrophy that AD patients have.
Finally, table 4-4 shows the effect of including the MMSE score in the classification.
Across all measurements, the sensitivity, specificity, and accuracy improved to almost
90%. As reported by the literature, experts rely heavily on neuropsychological scores to
diagnose AD and MCI stages. This creates a dependency, or bias, in the data with respect
to the MMSE score. Many experts recommend to not use the MMSE score in supervised
learning algorithms given that the class separation will already come biased by the
MMSE score. The machine learning realm contains other algorithms that don’t have this
problem. The unsupervised learning family of algorithms, such as clustering, allows
finding clusters of data that are similar to each other.
The effect of the MMSE score in the classification also exemplifies why feature selection
does not play a key role on this implementation of SVM. The algorithm is already
optimized to find the more significant features.
The Data balancing effect is not studied in our experiments. The ADNI data has a much
larger number of controls when compared to the AD subjects. The consequence is a
higher specificity value. In the ADNI data there are almost double the number of controls
than AD subjects. This means that the training size is larger for controls, as well as the
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classifiable control sample. The algorithm is better trained to detect controls, thus
reporting a higher specificity. A review of the literature shows that our classifier is as
good as those reported by other authors, as shown in table 6-1.
Table 4-5: Performance average comparison of AD/Control Classification.

AUTHORS
Zhang (2011) [38]
Magnin (2009) [39]
Kloppel(2008) [40]
Walhovd (2010) [41]
Cuingnet(2011) [42]
Zhou (2014) [43]
Proposed Classifier

DATASET(AD/CN) Sensitivity Specificity Accuracy
ADNI(51/52)
86%
86%
86%
Private(16/22)
91%
96%
94%
Private(33/57)
60%
93%
81%
ADNI(42/38)
81%
83.50%
82%
ADNI(162/137)
81%
95% Private{127/59)
84%
96%
92%
ADNI(139/76)
82%
91%
89%
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5.11

Validation Tests

MRI Values Validation

As cautioned earlier, FreeSurfer values obtained from the same FreeSurfer version can
vary among different hardware and software platforms. According to the FreeSurfer team,
this is due to OS-dependent libraries that support FreeSurfer. Hence, for this proposed
web interface, the replica servers (RSs) are calibrated, making sure they always provide
the same results before they are deployed. ADNI renders FreeSurfer results calculated on
FreeSurfer 5.1.
In order to validate NWSI, a paired T-test was performed to compare the values reported
in the ADNIMerge file and the NWSI results. 20 ADNI cases were selected at random
from the 4 main diagnoses ([AD, Early Mild Cognitive Impairment (EMCI), Late Mild
Cognitive Impairment (LMCI), and Cognitively Normal (CN))]. One of the selected
subjects failed ADNI’s quality control for the MidTemporal region, but it was
successfully processed by NWSI. See Table 1 below for the obtained results.
ADNIMerge and NWSI FreeSurfer results are highly correlated. There is a small
statistical difference for MidTemporal and Entorhinal cortex. ADNIMerge was processed
with FS5.1, and NWSI uses FS5.3. FreeSurfer 5.3 was a major upgrade to 5.1. Different
FreeSurfer versions produce different results, but it does not imply lack of validity.
Classification results can still be reliably used [44]. See Table 5-1 for results.
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Table 5-1: MRI Processing by Neuroimaging Web Services Interface (NWSI) Quality Control
Comparisons.

Measure
(mm3)

NWSI FS 5.3

ADNI Merge FS
5.1

Difference
(%)

Correlation

Paired T-Test *

Hippocampus

7041±1529

7043±1404

-3.00%

0.9866
(p<.0001)

-0.03
(.9788)

Entorhinal
Cortex

3252±717

3504±827

-6.50%

0.876
(p<.0001)

-2.8
(.01)

Middle
Temporal

19040

20020

-3.40%

.971
(p<.0001)

-5.3
(p,.0001)

ICV

1486538±154661

1482872±152534

2.40%

0.9944
(p<.0001)

-1.0
(0.33)

* H0: Difference=0

5.12

18F-Florbetapir PET Validation

NWSI PET SUVR values have been validated with the values on ADNI data as reported
by Jagust [45]. All ADNI PET results use 18F-Florbetapir. A random selection of 20
subjects from ADNI was used. Native PETs and MRIs were processed in NWSI, and the
calculated global SUVRs were compared to those reported by ADNI. A 2-tailed t-test
shows no statistical significance (t- Stat < t Critical two tails) as shown in Table 5-2.

5.13

18F-Florbetaben PET Validation

NWSI PET SUVR values have been validated using data from the Centiloid Project (CL),
as described in the data section above. The 35 subjects were uploaded to NWSI and the
results were compared to the ones reported by Dr. Rowe. A 2-tailed t-test was done on
the processed data and no statistical significant difference was found, see table 5-3
comparing the NWSI values to the ones reported by the CL team.
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These results are important because the CL team performed the registration and
calculation using SPM8. It validates NWSI not only with other versions of FreeSurfer,
but also with other software packages that provide segmentation and parcellation.
Table 5-2: T-Test-Paired comparing NWSI and ADNIMerge 18F-Florbetapir PET Global SUVR values.

NWSI

ADNIMERGE

1.22
0.047
18
0.93
0
17
0.26
0.40
1.74
0.79
2.11

Mean
Variance
Observations
Pearson Correlation
Hypothesized Mean Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

1.217
0.044
18

Table 5-3: T-Test-Paired comparing NWSI and CL 18F-Florbetaben PET Global SUVR values.
NWSI

Mean
Variance
Observations
Pearson
Hypothesized
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

CL

1.31
0.132
35
0.84
0
34
1.25
0.11
1.69
0.22
2.03
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1.26
0.127
35

6

6.11

Conclusion and Future Work

Retrospective

The initial intent of NWSI is fulfilled in order to create a tool for clinicians and
researchers with keen interest on Neuroimaging but do not necessarily have the time
and/or the required expertise in image processing, computing, and data management
resources. Most of the user interaction with the interface is limited to uploading the data
file, requesting the execution of a given task on the uploaded file, and performing quality
control on the provided output. The user can select to be notified via email or text
message after a long running task has completed.
NWSI initial code was written in 2012. Many details have changed since the original
prototype. The feedback provided by medical doctors and other researchers has been
invaluable. The system as currently developed is the result of many hours dedicated to
understanding the challenges of neuroimaging in brain research and for meeting the needs
and requirements of Medical Doctors (MDs). The medical images displayed in the
Papaya viewer contain layers defining the edge of the gray and white matter, custom
LUTs created based on how MDs visualize the specific results, and many other
enhancements which emerged from interacting with the medical team.
6.12

Main Findings

Data entry into NWSI is deemed most effective and user-friendly and has been evaluated
based on user feedback. The forms embedded into the interface are intuitive and similar
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to many other forms in the Internet. Uploading an MRI into NWSI is as simple as
updating a Facebook or Instagram status. Five papers in highly-ranked journals have
already been published based on data from NWSI, and several conference papers have
been written and published by our graduate students through the use of the NWSI
interface.
NWSI is shown to be an effective web platform for storing and processing neuroimaging
data. All data is de-identified prior to being uploaded to the server. NWSI is accessible
worldwide. The user interacts with the processing pipelines through a simple interactive
web-interface, which allows the users to upload and process images of the brain and view
the results directly on the browser. The multi-user interface allows for privacy among
researchers, as well as data sharing. Data is protected on the secured server, while
communication with the user is encrypted. Pipelines which process structural MRI and
Amyloid PET scans have been validated with existing and well-established databases.
NWSI stores all results in SQL tables and files, facilitating the selection and processing
of existing data into new pipelines. As such, NWSI offers a complete solution for
Neuroimaging Studies with multi-user tools for data processing and visualization, as well
as for downloading to another platform for further processing.
The SVM classifier on the web interface is comparable to other classifiers reported by the
literature and allows for the processing of other AD datasets. The results obtained from it
are also congruent with the consensus for the effect on volumetric atrophy of Alzheimer’s
disease. The classifier, as described, will make a great addition to any AD processing
pipeline.
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Heat maps provide an excellent visualization tool for brain images. Structural MRI
images with high resolution can be analyzed voxel by voxel, but PET, fMRI, and DTI
images are low resolution and typically a single voxel value is not as important as the
average for regions; that is why processing pipelines for these low-resolution modalities
study the behavior of regional average. Heat maps provide a simplification of these
images by showing the image as processing pipelines study them. They can aid in PET
visual rating and validating 3D source localization in Epilepsy.
Visual ratings and binary assessments are the gold standard in AD imaging research.
These methods are prone to error and biases when compared to the automated ones, such
as the ones implemented in NWSI. Nonetheless, collecting visual ratings allows
evaluating the reliability of raters, and can also be used to measure what role rater’s
expertise plays in the rating process. The NWSI Training website was created on data
previously analyzed in NWSI. This new interface connects to the NWSI results and
allows for visual rating of PETs and MRIs. Another important question is to measure
how expertise and knowledge of the brain anatomy influences the visual rating. Visual
ratings are done in the field by inspecting the images and using anatomy knowhow and a
rough training to label a PET as positive or negative. But NWSI training displays and
labels the regions, removing a layer of complexity from the rating process. NWSI
training can provide insights into how non-experts on the field are also able to visually
rate PET images correctly just like experts would. Furthermore, the visual rating interface
allows a rater located in a different location to collaborate and use a common interface.

82

Without such an interface it will not be possible to collect this type of data under the
control required for this type of study.
Another contribution of this research endeavor is in creating new heat maps which can be
a great aid for the visual rating of PET images. Such heat maps are shown to improve the
reliability of raters. Heat maps can model regions of the brain by coloring them based on
pre-calculated values. When analyzing brain images of low resolution, such as PETs and
DTI, the value of a specific voxel is typically not important. The processing algorithms
for these images typically produce regional values. By mapping these values into an
anatomical T1 image, a visual simplification of the low-resolution image is produced to
better represent the processed data.
The NWSI platform allows for users to execute online newly developed machine learning
algorithms that were proven to be highly effective in terms of their classification and
predictive outcomes. Currently, the interface provides access to an SVM (Support Vector
Machine) algorithm to separate binary classes in AD. The algorithm is connected to a
sample of the ADNI database. Many of the options are exported to the classification form
and can be configured using the interface.
In terms of image restoration, The NWSI interface proposes a method that partially
restores the structural MRIs that experience shading in certain regions of the brain.tThis
type of shading that occurs due to some human error in the image acquisition process is
found to affect, in a critical way, calculations of the ICV measure and corrupts as well as
the volumetric and surface measures of these shaded areas of the brain due to inaccurate
image segmentation of the different brain regions. These shading changes, although
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found in only small sections of the brain could potentially skew the classification process
of the different prodromal stages of Alzheimer’s disease. We have shown through this
type of image restoration, the ICV values are accurately measured. All the MRI images
were obtained using the same scanner and apparently under the same conditions, so the
created model was applicable to all. The method can be modified to create a model for
each image (or group of images) if they have different rates of shading. In so doing, we
have saved time and money for having many of the individuals who have taken these
MRIs not to retake them.
We have also proven that the image restoration method that was implemented was also
computationally effective. FreeSurfer has a method that allows a user to create control
points in the white matter in order to increase brightness in the vicinity of the point. But
this will mean that each image will have to be opened and edited individually. Processing
207 images will probably take a month or longer. The method proposed is capable of
creating a model and process the images in a few minutes and without need for human
interaction.
In terms of image segmentation, another contribution associated with the design of the
NWSI interface is in creating a contour as a form of segmentation delineating white
matter from gray matter as means to augment the prospects of PET visual ratings.
Currently, the gold standard for visually rating PETs is to display them in grayscale and
visually assessing the cortical regions in contrast to white matter solely on the basis of
brightness level. With the segmentation proposed in this dissertation, the expert rater is
able to delineate gray matter from white matter and hence the visual assessment is made
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better in terms of gauging the spread of the PET imaging tracer within the white matter
area.
On the Centiloid scale, although we have not designed the formula for the conversion to
the centiloid scale, we thought that it was important to include such conversion to the
centiloid scale into the NWSI platform on the basis of a data collection problem we have
personally faced in the design of this web interface. In the process of collecting data for
the 1Florida ADRC, we have switched from one company (Amyvid) that provided PET
images using the Florbetapir agent to another company (Neuraceq) that provided us PET
imaging using the Florbetaben agent. Although both tracers are approved and work
equally well, we faced the problem of consolidating these Florbetapir and Florbetaben
PET data on a similar scale, the centiloid scale, so that both datasets could be integrated
in our processing and statistical analysis.
Through this process, we were able to integrate 185 florbetaben PET images obtained
through Neuraceq with the 45 Florbetapir PET images that were acquired through
Amyvid. This was quite an exploit as we are capable to maintain all of our patients and
normal controls and be able to use all of them in the development of the web interface
and related image processing algorithms, and in the statistical analyses that were
conducted. This could also accommodate other researchers who may run into similar
problem who maybe using one form of these agents and be able to combine their data to
other datasets that may have been acquired through a different agent. It is also
conceivable that newer PET agents could be developed in the future and that variations of
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this scaling method could be implemented to sustain such an integration of PET data
acquired under different PET imaging agents.
6.13

Future Work

New studies are added every month to NWSI. As more data is uploaded, it is possible to
create methods for merging similar data from different sources. This allows, for example,
using the control scans from one account to enhance another study lacking controls.
Multimodal pipelines can also be created based on merging PET, structural and
functional MRI and DTI. The current implementation does not process fMRI, and the
DTI processing is currently very limited. Expanding those pipelines will allow
multimodal pipelines to be created for enhanced multimodal studies. New processing
pipelines can be exposed to the user, allowing inclusion of previously processed cases
and broadening the scope of new studies.

FreeSurfer and FSL were the natural choice for segmentation and registration because
ADNI data was available and already processed by FS and FSL. There are other software
packages which also provide excellent results: 3D Slicer, AFNI, SPM, etc. As a future
development it will be possible to add pipelines employing these software packages and
for the user to select which one to use at the upload form.

The heat maps interface allows the visual modeling of regional values. In the examples
presented we mentioned that when modeling SUVR values, it can differentiate positive
from negative PET scans. The ability to model averages brings raters a step closer to
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agreement as one of the mental processes they have to do is precisely estimate this
average. Heat maps have the potential to become a tool for aiding raters to reach higher
agreements in their results.
The SVM classifier can be used to run additional experiments than the ones reported in
this study. More Kernels are available to SVM. The data balancing option might aid in
lowering the specificity, but its effect on sensitivity is to be determined. Another great
addition will be to study how an unsupervised learning algorithm performs with the
MMSE score added. There are other features that can be included in the classification.
Genetic traits, SUVR values, resting state fMRI results, and DTI results can be added as
features together the volumetric measurements to improve the classification.
The research community needs to put more focus on multiclass classification algorithms
to overcome the limitations of binary classifications. More focus should also be placed
for multimodal imaging with more advanced machine learning algorithms for both
classification and prediction involving longitudinal studies to overcome the collinearity
issue of cross-sectional studies.
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